What a buyer sees
PRINCIPLE HEALTHCARE INTERNATIONAL LIMITED
Manufacture of basic pharmaceutical products · Leeds · 05019943
5staff · FY2025
22years trading
—oldest owner on file
£238kcash at bank
Your turnover is on public record
filed£1.3Mfor the year to 2025
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff5
20218 → 52025
Cash at bank£238k
2021£166k → £238k2025
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£255,000in the top quarter
£19,570£79,800£652,860
Debtor daysdays1below almost all
1552127
Creditor daysdays15
1033119
Stock daysdays0below almost all
944216
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 3
- One director on the registerA buyer's first question about a company run by one person is what happens to it if that person stops. It is usually the first thing priced.
- Headcount fell from 8 to 5A buyer sees the fall and not the reason. Deliberate tightening and losing people look identical on a filing.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 4
- 22 years of trading on fileLongevity is the cheapest evidence there is that the business is not one contract.
- Sales per employee better than three quarters of your tradeYours is 255,000 against 79,800 for the middle of 697 comparable companies.
- Debtor days better than three quarters of your tradeYours is 1 against 52 for the middle of 557 comparable companies.
- Stock days better than three quarters of your tradeYours is 0 against 44 for the middle of 533 comparable companies.
What the register says
Owners
Nobody recorded with significant control.
Directors
- 47since 2023
| Year to | Filed | Turnover | Staff | Cash |
|---|---|---|---|---|
| 2025-12-31 | 2026-09-10 | £1.3M | 5 | £238k |
| 2023-12-31 | — | £1.7M | 8 | £101k |
| 2022-12-31 | — | £2.0M | 8 | £25k |
| 2021-12-31 | — | £2.4M | 8 | £166k |
A rough bracket, and why it is only that
0.4–0.9× sales£510k£1.1M
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.